Abbott Reports Second-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Abbott Labs (ABT) PT Raised to $72 at Cowen
July 19, 2018 8:23 AM EDTCowen raised its price target on Abbott Labs (NYSE: ABT) to $72.00 (from $68.00) while maintaining a Outperform rating following solid Q2 results.
Analyst Joshua Jennings notes organic growth was 8%, versus 6%-7% guidance range and also north of the 7% organic rate shown in 1Q. Also, guidance was raised despite a strong dollar.
... MoreAbbott Labs (ABT) PT Raised to $70 at RBC Capital
July 19, 2018 7:16 AM EDTRBC Capital raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $67.00) while maintaining a Outperform rating.
Analyst Glenn Novarro said results again demonstrated powerful momentum across all four segments, especially outside the U.S.
... MoreAbbott Labs (ABT) PT Raised to $70 at Evercore ISI
July 18, 2018 12:19 PM EDTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $66.00) while maintaining a Outperform rating.
What analyst Vijay Kumar liked in the quarter:
8% organic topline came in above ST and whisper expectationsNutrition came in above (~2% above ST) and... MoreAbbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
July 18, 2018 7:47 AM EDTAbbott (NYSE: ABT) reported Q4 EPS of $0.73, $0.02 better than the analyst estimate of $0.71. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.76 billion.
GUIDANCE:
Abbott sees FY2019 EPS of $2.85-$2.91, versus the consensus of $2.86.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More